Different Dietary Interventions and Glycemia in T1DM
The Effect of Three Different Types of Diet on Glycemia Assessed by Continuous Glucose Monitoring in Patients With Type 1 Diabetes on Multiple Daily Insulin Treatment
1 other identifier
interventional
15
0 countries
N/A
Brief Summary
The aim of the present study was to compare the effects of three different dietary patterns on glycemia in individuals with type 1 diabetes (T1D).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2014
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2017
CompletedFirst Submitted
Initial submission to the registry
April 9, 2020
CompletedFirst Posted
Study publicly available on registry
April 13, 2020
CompletedApril 13, 2020
April 1, 2020
3 years
April 9, 2020
April 10, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of time spent with glucose levels between 70-140 mg/dl
Percentage of time spent with glucose levels between 70-140 mg/dl
7 days
Study Arms (3)
Mediterranean diet
ACTIVE COMPARATORMediterranean diet for 7 days
Low-carb/high protein diet
ACTIVE COMPARATORLow-carb/high protein diet for 7 days
Reference diet
ACTIVE COMPARATORReference diet for 7 days
Interventions
Crossover dietary manipulation using three different types of diet for 7 days each
Eligibility Criteria
You may qualify if:
- Adults with T1D receiving MDI therapy
- Sufficient education and knowledge on carbohydrate counting
- Motivation to follow a specific dietary schedule
- Frequent (7 times a-day) self-monitoring of blood glucose (SMBG)
- Willingness to wear a CGM system
You may not qualify if:
- HbA1c \>8%
- Lack of severe diabetic complications, such as cardiovascular disease, proliferative retinopathy, nephropathy with estimated glomerular filtration rate (eGFR) ≤ 60 or gastroparesis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alexandros Kokkinos, MD, PhD
Medical School, National and Kapodistrian University of Athens, Laiko Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor in Internal Medicine
Study Record Dates
First Submitted
April 9, 2020
First Posted
April 13, 2020
Study Start
November 1, 2014
Primary Completion
November 1, 2017
Study Completion
November 1, 2017
Last Updated
April 13, 2020
Record last verified: 2020-04
Data Sharing
- IPD Sharing
- Will not share